Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group

Sarcoma

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry

J Orthop Surg Res

Smolle MA, Hasenschwandtner S, Reichinger A, Koulaxouzidis G, Wenzl FA, Weiss L, Heregger R, Seeber A, Winder T, Taghizadeh H, Liegl-Atzwanger B, Leithner A, Szkandera J

doi: 10.1186/s13018-026-06894-1

Gastrointestinal Cancer

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Eur J Cancer

Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V

doi: 10.1016/j.ejca.2025.116105

Genitourinary Cancer

Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data

Prostate Cancer Prostatic Dis

Shore N, Morgans AK, Paracha N, Gallagher E, Thom H, Aceituno D, Orishaba P, Stefani S, Trinh QD, Wallis CJD, Abrams KR, Boegemann M

doi: 10.1038/s41391-025-01054-8

Sarcoma

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial

J Natl Cancer Inst

Oberoi S, Gao Z, Xue W, Randall RL, Coffin CM, Million L, Wolden S, McCarville MB, Kao SC, Venkatramani R, Spunt SL, Weiss AR

doi: 10.1093/jnci/djag211

Skin Cancer

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG

Eur J Cancer

Lallas K, Nanz L, Ugurel S, Mohr P, Meier F, Weichenthal M, von Wasielewski I, Terheyden P, Hassel J, Kreuter A, Herbst R, Gesierich A, Pföhler C, Gutzmer R, Welzel J, Gebhardt C, Haferkamp S, Ulrich J, Kaatz M, Meiss F, Berking C, Gambichler T, Livingstone E, Zimmer L, Flatz L, Forschner A, Schadendorf D, Hillen U, Leiter U

doi: 10.1016/j.ejca.2026.116582

Sarcoma

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center

Int J Cancer

Giraud JS, Watson S, Acramel A, Laurence V, Tzanis D, Bonvalot S, El Zein S, Nicolas N, Cros C, Desmaris R, Bonnet C

doi: 10.1002/ijc.70403

Sarcoma

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience

Eur J Cancer

Babatunde OO, Seier K, Desir-Camille R, Avutu V, Reinhorn D, Shahnam A, Maki RG, Gounder MM, Bartlett E, Keohan ML, Long K, Bose S, Banks L, Kelly CM, Chi P, Crago AM, D'Angelo SA, Dickson MA, Qin LX, Tap WD, Movva S

doi: 10.1016/j.ejca.2026.117012

Genitourinary Cancer

First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis

J Urol

Miyajima K, Miszczyk M, Matsukawa A, Roessler N, Inoue S, Urabe F, Mori K, Yanagisawa T, Karakiewicz PI, Agarwal N, Briganti A, Kimura T, Shariat SF

doi: 10.1097/JU.0000000000005131

Sarcoma

Deni Study: Real-World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group

Int J Cancer

Kubicek P, Guérin-Charbonnel C, Toulmonde M, Boudou-Rouquette P, Thibaud V, Penel N, Italiano A, Ryckewaert T, Firmin N, Bertucci F, Dufresne A, Soulié P, Perrin C, Noal S, Brahmi M, Blay JY, Bompas E

doi: 10.1002/ijc.70672

Related content

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience

First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis

Deni Study: Real-World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group